Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 874,103Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7AbbVie Corporation

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

LINACLOTIDE

Brand Name : CONSTELLA

Patent Number : 2514507

Filing Date : 2004-01-28

Strength per Unit : 145 ?g

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-01-28

Date Granted : 2012-03-20

Abbvie CB

02

LINACLOTIDE

Brand Name : CONSTELLA

Patent Number : 2514507

Filing Date : 2004-01-28

Strength per Unit : 290 ug

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-01-28

Date Granted : 2012-03-20

Abbvie CB

03

AbbVie Corporation

arrow
Coatings Trends
Not Confirmed

AbbVie Corporation

Country
arrow
Coatings Trends
Not Confirmed

LINACLOTIDE

Brand Name : CONSTELLA

Patent Number : 2732892

Filing Date : 2009-08-14

Strength per Unit : 290 ug

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-08-14

Date Granted : 2020-12-15

blank

04

AbbVie Corporation

arrow
Coatings Trends
Not Confirmed

AbbVie Corporation

Country
arrow
Coatings Trends
Not Confirmed

LINACLOTIDE

Brand Name : CONSTELLA

Patent Number : 2514507

Filing Date : 2004-01-28

Strength per Unit : 72 ?g

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-01-28

Date Granted : 2012-03-20

blank

05

AbbVie Corporation

arrow
Coatings Trends
Not Confirmed

AbbVie Corporation

Country
arrow
Coatings Trends
Not Confirmed

LINACLOTIDE

Brand Name : CONSTELLA

Patent Number : 2808091

Filing Date : 2011-08-11

Strength per Unit : 72 ?g

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2031-08-11

Date Granted : 2019-05-21

blank

06

AbbVie Corporation

arrow
Coatings Trends
Not Confirmed

AbbVie Corporation

Country
arrow
Coatings Trends
Not Confirmed

LINACLOTIDE

Brand Name : CONSTELLA

Patent Number : 2732892

Filing Date : 2009-08-14

Strength per Unit : 145 ?g

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-08-14

Date Granted : 2020-12-15

blank

07

AbbVie Corporation

arrow
Coatings Trends
Not Confirmed

AbbVie Corporation

Country
arrow
Coatings Trends
Not Confirmed

LINACLOTIDE

Brand Name : CONSTELLA

Patent Number : 2732892

Filing Date : 2009-08-14

Strength per Unit : 72 ?g

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-08-14

Date Granted : 2020-12-15

blank